Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Launches AmnioExcel® Plus Placental Allograft Membrane
The Next Generation in Amniotic Tissue Products PRINCETON, N.J. , Feb. 24, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of AmnioExcel ® Plus Placental Allograft Membrane, its latest wound
View HTML
Toggle Summary Integra LifeSciences Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides 2020 Financial Guidance
PRINCETON, N.J., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2019 and issued its financial guidance for 2020, consistent with the preliminary results and guidance
View HTML
Toggle Summary Integra LifeSciences to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call on February 19, 2020
PRINCETON, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full-year 2019 financial results on Wednesday, February 19, 2020 prior to market open.
View HTML
Toggle Summary Integra Announces Pricing of Convertible Senior Notes
PRINCETON, N.J., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced the pricing of $500,000,000 aggregate principal amount of 0.5% convertible senior notes due 2025 (the “Notes”). The Notes were offered and sold in a private placement solely to
View HTML
Toggle Summary Integra Announces Amendment and Extension of Credit Facility and Private Placement of Convertible Senior Notes
PRINCETON, N.J., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has amended and extended its credit facility and commenced a private offering of convertible senior notes. Amendment and Extension of Credit Facility Integra today
View HTML
Toggle Summary Integra LifeSciences Announces Preliminary Fourth Quarter and Full-Year 2019 Revenue Results and 2020 Financial Guidance
Fourth quarter 2019 reported revenue is expected to be at or near the low end of the previously communicated guidance range of $395 to $400 million, representing organic revenue growth of slightly less than 5% and reported growth of approximately 3%; For the full-year 2020, the company is providing
View HTML
Toggle Summary Integra LifeSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced President and Chief Executive Officer Peter Arduini will speak at the 38 th Annual J.P.
View HTML
Toggle Summary Integra LifeSciences to participate in the Piper Jaffray 31st Annual Healthcare Conference
PRINCETON, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Carrie Anderson, chief financial officer, will present at the Piper Jaffray 31 st Annual Healthcare Conference in New York
View HTML
Toggle Summary Integra LifeSciences to participate in the 28th Annual Credit Suisse Healthcare Conference
PLAINSBORO, NJ, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the 28 th Annual Credit Suisse Healthcare Conference in Scottsdale, Arizona on Tuesday, November 12, 2019 at 1:15 p.m.
View HTML
Toggle Summary Integra LifeSciences Reports Third Quarter 2019 Financial Results
Reported revenues increased 3.6% to $379.1 million; organic revenues increased 4.7%  GAAP and adjusted earnings per diluted share were $(0.32) and $0.68, respectively The Company is tightening the range for its full-year reported revenue guidance and reaffirming full-year organic revenue growth
View HTML
Toggle Summary Integra LifeSciences to Host Third Quarter 2019 Earnings Results Conference Call on October 24, 2019
PLAINSBORO, N.J., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2019 financial results on Thursday, October 24, 2019, prior to market open.
View HTML
Toggle Summary Integra LifeSciences Supports the European Burns Association’s “Share your Care” Educational Program
PLAINSBORO, N.J., Sept. 23, 2019 (GLOBE NEWSWIRE) -- During the 18 th European Burns Association (EBA) Congress, which took place in Helsinki, Finland, from 4 to 7 September 2019, Integra LifeSciences announced its support for EBA through an educational grant for their “Share your Care” junior
View HTML
Toggle Summary Integra LifeSciences Presents Cadence® Total Ankle System Retrospective Study Abstract at AOFAS
PLAINSBORO, N.J., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART ), a leading global medical technology company, today announced positive findings from its Cadence® Total Ankle System  retrospective study. Tim Daniels, MD, FRCSC, Professor, University of
View HTML
Toggle Summary Integra LifeSciences Acquires Rebound Therapeutics Corporation
Acquisition Adds New, Minimally Invasive Platform for Neurosurgery PLAINSBORO, N.J., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced today that it has acquired Rebound Therapeutics, developers of
View HTML
Toggle Summary Integra LifeSciences to participate in the Wells Fargo 2019 Healthcare Conference and the Morgan Stanley 17th Annual Global Healthcare Conference in September 2019
PLAINSBORO, N.J., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in September: On Thursday, September 5, 2019 at 1:55 p.m.
View HTML